Original communication| Volume 139, ISSUE 5, P617-623, May 2006

RETRACTED: Efficacy of accelerated partial breast irradiation as a neoadjuvant treatment for patients with breast cancer: A pilot study

      This paper is only available as a PDF. To read, Please Download here.
      This article has been retracted at the request of the Editors. Please see
      Reason: It has been called to our attention by one of the indentified authors, Dr. Minoru Uematsu of Keio University School of Medicine, that he did not contribute to this paper and was unaware of its submission. In addition, Dr. Uematsu informs us that the data appear to be an updated version without attribution to his presentation at the 22nd Annual San Antonio Breast Cancer Symposium December 8–11, 1999 (previously published as an abstract (Breast Cancer Research and Treatment 1999; 57:108). Dr. Uematsu also states that the information contained in the SURGERY article is misleading and inaccurate in that the patients were treated with whole breast irradiation in addition to the accelerated partial breast irradiation, a fact that was not stated in the article. The Editors feel that this is a serious misrepresentation of the treatment method.
      The Editors have contacted Kazuhiko Sato, M.D., Ph.D., who submitted the manuscript for publication and is its first author. Dr. Sato concedes and apologizes for (1) the listing of Dr. Uematsu as an author without his permission, (2) failing to provide the attribution to the original presentation and (3) omitting the crucial fact that conventional whole breast irradiation of 50 Gy was used as a further treatment of patients receiving the APBI.
      With these facts in hand, it is regrettable but necessary that we retract this article in its entirety.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect